CRP and type 2 diabetes mellitus: Growing evidence has proposed that elevated blood concentrations of circulating inflammatory markers, such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and high-sensitivity C-reactive protein (hs-CRP), can enhance the development of T2DM [13,14,15,16,17].